BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19494278)

  • 1. Altered expression of 15-hydroxyprostaglandin dehydrogenase in tumor-infiltrated CD11b myeloid cells: a mechanism for immune evasion in cancer.
    Eruslanov E; Kaliberov S; Daurkin I; Kaliberova L; Buchsbaum D; Vieweg J; Kusmartsev S
    J Immunol; 2009 Jun; 182(12):7548-57. PubMed ID: 19494278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression.
    Kaliberova LN; Kusmartsev SA; Krendelchtchikova V; Stockard CR; Grizzle WE; Buchsbaum DJ; Kaliberov SA
    Mol Cancer Ther; 2009 Nov; 8(11):3130-9. PubMed ID: 19887544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidine.
    Daurkin I; Eruslanov E; Vieweg J; Kusmartsev S
    Cancer Immunol Immunother; 2010 May; 59(5):697-706. PubMed ID: 19882154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE₂ catabolism in myeloid cells.
    Eruslanov E; Daurkin I; Ortiz J; Vieweg J; Kusmartsev S
    J Leukoc Biol; 2010 Nov; 88(5):839-48. PubMed ID: 20587738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes.
    Miyaki A; Yang P; Tai HH; Subbaramaiah K; Dannenberg AJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G559-66. PubMed ID: 19608733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
    Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant PGE₂ metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cells.
    Eruslanov E; Daurkin I; Vieweg J; Daaka Y; Kusmartsev S
    Int Immunopharmacol; 2011 Jul; 11(7):848-55. PubMed ID: 21315786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib enhances the efficacy of 15-hydroxyprostaglandin dehydrogenase gene therapy in treating murine breast cancer.
    Zhang B; Ma X; Li Z; Gao X; Wang F; Liu L; Shen G; Sang Y; Li M; Li Y; Zhao J; Wei Y
    J Cancer Res Clin Oncol; 2013 May; 139(5):797-807. PubMed ID: 23385883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells.
    Moore AE; Greenhough A; Roberts HR; Hicks DJ; Patsos HA; Williams AC; Paraskeva C
    Carcinogenesis; 2009 Oct; 30(10):1796-804. PubMed ID: 19638428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy.
    Na HK; Park JM; Lee HG; Lee HN; Myung SJ; Surh YJ
    Biochem Pharmacol; 2011 Nov; 82(10):1352-60. PubMed ID: 21856294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells.
    Mehdawi LM; Satapathy SR; Gustafsson A; Lundholm K; Alvarado-Kristensson M; Sjölander A
    Oncotarget; 2017 May; 8(21):35033-35047. PubMed ID: 28402256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer.
    Backlund MG; Mann JR; Holla VR; Buchanan FG; Tai HH; Musiek ES; Milne GL; Katkuri S; DuBois RN
    J Biol Chem; 2005 Feb; 280(5):3217-23. PubMed ID: 15542609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
    Thiel A; Ganesan A; Mrena J; Junnila S; Nykänen A; Hemmes A; Tai HH; Monni O; Kokkola A; Haglund C; Petrova TV; Ristimäki A
    Clin Cancer Res; 2009 Jul; 15(14):4572-80. PubMed ID: 19584167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1β from activated macrophages leads to poor prognosis in pancreatic cancer.
    Arima K; Komohara Y; Bu L; Tsukamoto M; Itoyama R; Miyake K; Uchihara T; Ogata Y; Nakagawa S; Okabe H; Imai K; Hashimoto D; Chikamoto A; Yamashita YI; Baba H; Ishimoto T
    Cancer Sci; 2018 Feb; 109(2):462-470. PubMed ID: 29224225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.
    Castro-Sánchez L; Agra N; Llorente Izquierdo C; Motiño O; Casado M; Boscá L; Martín-Sanz P
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2501-11. PubMed ID: 23954207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cells.
    Smartt HJ; Greenhough A; Ordóñez-Morán P; Talero E; Cherry CA; Wallam CA; Parry L; Al Kharusi M; Roberts HR; Mariadason JM; Clarke AR; Huelsken J; Williams AC; Paraskeva C
    Gut; 2012 Sep; 61(9):1306-14. PubMed ID: 22082586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury.
    Yao L; Chen W; Song K; Han C; Gandhi CR; Lim K; Wu T
    PLoS One; 2017; 12(4):e0176106. PubMed ID: 28423012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 15-Hydroxyprostaglandin dehydrogenase suppresses K-RasV12-dependent tumor formation in Nu/Nu mice.
    Pham H; Eibl G; Vincenti R; Chong B; Tai HH; Slice LW
    Mol Carcinog; 2008 Jun; 47(6):466-77. PubMed ID: 18058808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin catabolic enzymes as tumor suppressors.
    Tai HH
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):409-17. PubMed ID: 22020925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-canonical WNT5A signaling up-regulates the expression of the tumor suppressor 15-PGDH and induces differentiation of colon cancer cells.
    Mehdawi LM; Prasad CP; Ehrnström R; Andersson T; Sjölander A
    Mol Oncol; 2016 Nov; 10(9):1415-1429. PubMed ID: 27522468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.